RENAVOTIO, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2022-10-05: Form 8-K; Period of report 2022-10-04; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2022-09-06: Form 8-K; Period of report 2022-09-06; Description 8.01 Other Events; Details 8.01.
- 2022-07-19: Form 8-K; Period of report 2022-05-11; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
- 2022-07-07: Form 8-K; Period of report 2022-07-01; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2022-10-05 | 8-K | 2022-10-04 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On October 4, 2022, Brian Kistler, resigned as a member of our Board of Directors and as our Chief Compliance Officer (the “Resignation”). | riii_8k.htm |
| 2022-09-06 | 8-K | 2022-09-06 | 8.01 Other Events | 8.01 On September 6, 2022, we will publish a press release titled “Renavotio, Inc. (RIII) Engages Corporate Accounting Firm and Expands its Cranberry Glove Business with Contracts Totaling $177,500,000”, which press release is attached hereto as Exhibit 99.1. | riii_8k.htm |
| 2022-07-19 | 8-K | 2022-05-11 | 1.01 Entry into a Material Definitive Agreement | 1.01 On July 18, 2022, we entered into a Purchase order for $40,575,000 for Cranberry Evolve 300’s, which are 100% powder free nitrile medical examination gloves. | riii_8k.htm |
| 2022-07-07 | 8-K | 2022-07-01 | 1.01 Entry into a Material Definitive Agreement | 1.01 On July 1, 2022, we entered into a 10% Promissory Note (the “Note”) attached hereto as Exhibit 10.1 (and related July 1, 2022 Securities Purchase Agreement attached hereto as Exhibit 10.2) with Tysadco Partners, LLC, a New York Limited Liability Company, for the Principal Amount of $50,000, an Original Issue Discount of $5,000, a Maturity Date of July 1, 2023, and a conversion rate of 80% multiplied by the lowest VWAP for our Common Stock during the ten (10) Trading Day period ending on the latest complete trading day prior to the conversion date. | riii_8k.htm |
| 2022-06-29 | 8-K/A | 2022-05-13 | 8.01 Other Events | 8.01 On May 13, 2022, we filed a Form 8-K with a May 13, 2022 Shareholder Update titled “Renavotio, Inc. (RIII) Provides Shareholder Updates”, which Shareholder Update stated that “we will strive to have all our SEC filings to be current by the end of June” [2022]. | riii_8ka.htm |
| 2022-05-25 | 8-K | 2022-05-20 | 8.01 Other Events | 8.01 On May 20, 2022, Renavotio Medical, LLC, an Oklahoma Limited Liability Company and our wholly owned subsidiary (“Renavotio Medical”), and Kyocera Medical Technologies, Inc , a California corporation (“Kyocera”), completed a Reseller Agreement between the two companies. | riii_8k.htm |
| 2022-05-13 | 8-K | 2022-05-13 | 8.01 Other Events | 8.01 On May 13, 2022, we will publish a Shareholder Update titled “Renavotio, Inc. (RIII) Provides Shareholder Updates”, which Shareholder Update is attached hereto as Exhibit 99.1. | riii_8k.htm |
| 2022-04-05 | 8-K | 2022-04-05 | 8.01 Other Events | 8.01 On April 5, 2022, we posted our updated Corporate Presentation Deck at our website, Renavotio.com, which is also attached hereto as Exhibit 99.1. | riii_8k.htm |
| 2022-03-31 | 8-K | 2022-03-31 | 8.01 Other Events | 8.01 We received a complaint in the matter of Walnut Creek Neighbors or Concerned Citizens (of various Oklahoma Counties) v. | riii_8k.htm |
| 2022-03-30 | 8-K | 2022-03-30 | 8.01 Other Events | 8.01 On March 30, 2022, we will publish a Shareholder Update titled “Renavotio, Inc. (RIII) Provides Shareholder Update”, which Shareholder Update is attached hereto as Exhibit 99.1. | riii_8k.htm |
| 2022-03-11 | 8-K | 2022-03-09 | 8.01 Other Events | 8.01 On March 9, 2022, on behalf of our wholly-owned subsidiaries (as referenced below), we fully paid off the following outstanding principal and interest note balances from various lenders: (a) $822,133.20 for Utility Management and Construction, LLC (“Utility Management”); ( b) $34,246.16 for Utility Management; (c) $52,186.07 for Cross-Bo Construction, LLC (“Cross Bo”); and (d) $37,978.25 for Cross-Bo. | riii_8k.htm |
| 2022-03-08 | 8-K | 2022-03-04 | 1.01 Entry into a Material Definitive Agreement | 1.01 On March 4, 2022, pursuant to a collateralized thirty (30) year promissory note (the “Note”) with the Small Business Administration (“SBA”), our wholly owned subsidiary, Utility Management and Construction, LLC (the “Borrower”), received loan proceeds of $1,915,200 from the SBA. | riii_8k.htm |
| 2022-02-24 | 8-K | 2022-02-24 | 8.01 Other Events | 8.01 On February 24, 2022, we will publish a Press Release titled “Renavotio, Inc. (RIII) Closed Purchase of its $1.7 Million Dollar Order and Acquires Another $2.1 Million Dollars of PPE Medical Examination Gloves”, which press release is attached hereto as Exhibit 99.1. | riii_8k.htm |
| 2022-02-15 | 8-K | 2022-02-15 | 8.01 Other Events | 8.01 On February 15, 2022, we will publish a Press Release titled “Renavotio, Inc. Announces Filings Status and Shareholder Updates”, which is attached hereto as Exhibit 99.1. | riii_8k.htm |
| 2022-01-14 | 8-K | 2022-01-14 | 8.01 Other Events | 8.01 The information in this Current Report on Form 8-K with respect to Item 8.01 (including Exhibits 99.1) is being furnished pursuant to Item 8.01 of Form 8-K and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act. | riii_8k.htm |
| 2022-01-03 | 8-K | 2022-01-03 | 8.01 Other Events | 8.01 On December 31, 2021, we published a Shareholder Update titled “Renavotio, Inc. (OTC: RIII) Provides Shareholder Update for 2022, which is attached hereto as Exhibit 99.1. | riii_8k.htm |
| 2022-01-03 | 8-K | 2022-01-03 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 8.01 Pursuant to our request for an extension to complete our third quarter Form 10-Q for the period ending September 30, 2021, OTC Markets originally granted us an extension until February 15, 2022 to file our third quarter Form 10-Q in order to maintain our OTCQB status, which we advised the public of via a December 31, 2021 Shareholder Update. | riii_8k.htm |